Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
about
Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease markerGlycation of nail proteins: from basic biochemical findings to a representative marker for diabetic glycation-associated target organ damageThe true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysisGlycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia.Serum glycated albumin as a new glycemic marker in pediatric diabetesThe ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetesEvidence for consistency of the glycation gap in diabetes.Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic RatsExploring the relationship between diabetes self-efficacy, depressive symptoms, and glycemic control among men and women with type 2 diabetes.Basic performance of an enzymatic method for glycated albumin and reference range determination.Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practicePostmortem diagnosis of diabetes mellitus and its complications.Effect of high glucose concentrations on human erythrocytes in vitroInhibitory potential of pure isoflavonoids, red clover, and alfalfa extracts on hemoglobin glycosylation.Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey.What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements.Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3)A review of glycated albumin as an intermediate glycation index for controlling diabetes.Surrogate end points: how well do they represent patient-relevant end points?Review of hemoglobin A(1c) in the management of diabetes.Current controversies in the use of haemoglobin A1c.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Glycated albumin: from biochemistry and laboratory medicine to clinical practice.Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.Assessment of two culturally competent diabetes education methods: individual versus individual plus group education in Canadian Portuguese adults with type 2 diabetes.Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments.Long-term prognostic value of admission haemoglobin A1c (HbA1c) levels in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes.Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study.Standardisation of glycated haemoglobin.Mechanisms responsible for the vascular effect of aqueous Trigonella foenum-graecum leaf extract in diabetic rats.The Role of Adrenergic and Angiotensinergic Systems in Vascular Effect of Alcoholic of Extract Trigonella foenum-graecum Seed in Diabetic Rats.Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus.The modulation of erythrocyte Na(+)/K(+)-ATPase activity by curcumin.Modulation Effects of Curcumin on Erythrocyte Ion-Transporter Activity.A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects.Prevalence and determinants of hyperglycaemia in pneumonia patients.
P2860
Q27012452-C26D5C88-501A-41C0-A518-1D7DD8C9CF19Q28544417-150E0D00-0C78-4A79-9F08-929C69DF457EQ30485840-2950F84D-D40F-4B9E-A33A-1F22EA70D1EFQ33255498-4E28CD8E-7BF1-4281-A97D-B1AC2355B8CEQ33602138-F35729A3-8D2B-43AC-A9C3-ABA1D460668CQ33609756-D3BE74E2-6E18-4A14-BBC5-CC889AB82455Q33635293-56643B62-A7F9-4AC5-A25D-8587CBFB0E00Q33809715-A3B83D3D-A3FC-4FF4-A796-ED74EE4E23B9Q35123412-C90C4ABE-304A-49E0-87D3-EE066A88437AQ35138113-E4B9306B-554E-4416-A622-0E5BEB3DD113Q35618734-03D4645A-6DFC-4F83-ACCD-F9E9C99397ABQ35684958-9812E9EC-451E-4459-A2B6-5EC4EF229294Q35684965-761FEFC5-9576-4533-9520-238535601CD8Q35847872-A2069199-BE15-4C68-A730-1C20FF406B20Q35864917-D5BB17E7-DF86-4CE8-A36E-98568057BFC2Q36055376-9DBF8AFD-2C78-424A-B299-B7F08EEB1382Q36329179-BBB261B2-A296-4DE2-8E78-6FDD9DC3D611Q36536741-2326DD82-CFBF-4820-A1BE-D133C4D7CDDAQ37403957-0639F07C-3D12-43D0-ABDC-4AA650B3874BQ37404327-842BCC33-A972-46C6-A54E-D15ED37BE549Q37755085-F82A4157-EAA0-474C-B142-C7FDC34AE351Q37798056-6CB03A96-CAF2-4855-A4C9-B472D04DF727Q37983923-C59C5C7D-3D38-432F-B578-11F4E8EB740AQ38182542-DF06A11B-5E95-4487-9092-063C885C86F9Q38953440-87027382-0E6B-4293-8411-55DB0B74F09EQ39372684-B8E42560-A116-48BD-8F8F-5D6F8C316163Q39790037-4974FE28-2FBA-44D7-A24F-86985B42F208Q41054147-E4BA6725-A18C-42F3-902F-F0F94D39751BQ41829352-3C00132D-0132-49EE-B0CB-6BD34A0C7646Q41930786-98DC41F8-89EF-4F6B-809D-7C798F7BF1C7Q41984076-C1486DF5-E49C-49A4-8AB5-84C6EE49728CQ42371747-55AC1BA2-629B-4FD7-BCBF-62BBDC33B007Q42427005-31C10237-408D-45A5-B2D7-8EF6231261E6Q42577512-52CC38E7-7EF4-4C11-986F-73A9AA9F9C32Q42781863-25820E7E-08A4-4892-BAB5-C8895EC2AB13Q43178550-D2A26812-D725-4452-A779-F5F15EB50869Q43179365-5629AB4B-D3AF-4ABA-88A9-0BF3E1DA6AD5Q43248493-68EBDE58-D651-47D1-B174-2111E3BB4CF0Q43740705-D598B934-E11C-49AF-BC00-A358F6770456Q44169122-AFB5BD8D-9053-4CA4-86E0-58D00079E13D
P2860
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@ast
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@en
type
label
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@ast
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@en
prefLabel
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@ast
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@en
P2860
P1433
P1476
Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
@en
P2093
Jeffcoate SL
P2860
P304
P356
10.1046/J.1464-5491.2003.01065.X
P577
2004-07-01T00:00:00Z